X0206 3 2023-06-01 0 0001601485 Elicio Therapeutics, Inc. ELTX 0001230486 ADAMS JULIAN C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501 BOSTON MA 02210 true Stock Option (right to buy) 13.81 2032-03-31 Common Stock 1357 D Stock Option (right to buy) 9.39 2030-09-02 Common Stock 1810 D Stock Option (right to buy) 4.42 2028-03-20 Common Stock 2172 D Stock Option (right to buy) 4.42 2027-01-20 Common Stock 4525 D Stock Option (right to buy) 9.94 2028-11-15 Common Stock 7266 D Stock Option (right to buy) 3.87 2032-12-06 Common Stock 34186 D Shares of capital stock of the corporation then known as Elicio Therapeutics, Inc. ("Old Elicio") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of January 17, 2023, by and among the Issuer, Arkham Merger Sub, Inc. and Old Elicio (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of capital stock was exchanged for 0.0181 shares of the Issuer's common stock, giving effect to a reverse split of the Issuer's common stock of 10-to-1. Represents 1,357 stock options granted under the Issuer's 2012 Equity Incentive Plan. Twenty five percent (25%) of the stock options vest on the one-year anniversary of March 31, 2022 with the remaining options vesting in equal monthly installments over a three-year period thereafter. Represents 1,810 stock options granted under the Issuer's 2012 Equity Incentive Plan. Twenty five percent (25%) of the stock options vest on the one-year anniversary of August 7, 2020 with the remaining options vesting in equal monthly installments over a three-year period thereafter. Represents 2,172 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options are fully vested. Represents 4,525 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options are fully vested. Represents 7,266 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options are fully vested. Represents 34,186 stock options granted under the Issuer's 2022 Equity Incentive Plan. Twenty five percent (25%) of the stock options vest on the one-year anniversary of December 6, 2022 with the remaining options vesting in equal monthly installments over a two-year period thereafter. Exhibit 24.1 - Power of Attorney. /s/ Nishant M. Dharia, Attorney-in-fact 2023-06-07